4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000130
Director sold 100 shares at an average $1,048.78 ($104,878)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
RYAN ARTHUR F · Director
Table I: Non-derivative
17 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-01 | Sale : show line 1 in the form 10b5-1 | −3 | $1,041.35 | $3,124 | 17,679 | D |
| 2024-10-01 | Sale : show line 2 in the form 10b5-1 | −1 | $1,042.31 | $1,042 | 17,678 | D |
| 2024-10-01 | Sale : show line 3 in the form 10b5-1 | −5 | $1,043.39 | $5,217 | 17,673 | D |
| 2024-10-01 | Sale : show line 4 in the form 10b5-1 | −9 | $1,044.62 | $9,402 | 17,664 | D |
| 2024-10-01 | Sale : show line 5 in the form 10b5-1 | −7 | $1,045.27 | $7,317 | 17,657 | D |
| 2024-10-01 | Sale : show line 6 in the form 10b5-1 | −9 | $1,046.53 | $9,419 | 17,648 | D |
| 2024-10-01 | Sale : show line 7 in the form 10b5-1 | −12 | $1,047.44 | $12,569 | 17,636 | D |
| 2024-10-01 | Sale : show line 8 in the form 10b5-1 | −12 | $1,048.54 | $12,582 | 17,624 | D |
| Open-market sales · 100 sh · avg $1,048.78 · $104,878 | ||||||
Loading xslF345X05/edgardoc.xml…